ViroXis Lands $2,500,000 New Funding Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=45835c5f-fe68-4ec3-8031-598ab8a25dd5&Preview=1 Date 10/15/2010 Company Name ViroXis Mailing Address 1261 Silicon Drive San Antonio, TX 78249 Company Description The company develops botanical pharmaceuticals. Website http://www.viroxis.com Transaction Type Venture Equity Transaction Amount $2,500,000 Transaction Round Undisclosed Proceeds Purposes The capital will be used to advance development and commercialization of San Antonio, Texas-based ViroXis’ topical Albuterpenoid anti-viral treatment of skin warts. M&A Terms Venture Investor Texas Emerging Technology Fund